Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial

por Holbrook, Reece, Higuera, Lucas, Wherry, Kael, Phay, Dave, Hsieh, Yu-Cheng, Lin, Kuo-Hung, Liu, Yen-Bin
Publicado 2020